Neurology Central

Advances in therapies and scope for personalized medicine in Alzheimer’s disease


Alzheimer’s disease is one of the leading causes of death worldwide and currently does not have any cure. The rate of incidence of Alzheimer’s from 2010 is up by 71%, whereas many other diseases have been decreasing in their prevalence. In this review, we have attempted to cover the current landscape of treatment alongside forthcoming advances. We have also covered the present genes identified through genome-wide association studies, which could be used as novel biomarkers and could eventually reduce the cost of treatment through early diagnosis.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.